Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 85

Results For "gene"

4216 News Found

Thyrocare’s Bharat Aarogyam score flags silent health risks in 9 out of 10 Indians
Healthcare | April 07, 2026

Thyrocare’s Bharat Aarogyam score flags silent health risks in 9 out of 10 Indians

Analysis of over 93 lakh preventive health checkups reveals disease risks emerging as early as the 20s


Experts advocate holistic Semaglutide use as therapy goes off patent in India
Healthcare | April 06, 2026

Experts advocate holistic Semaglutide use as therapy goes off patent in India

They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market


Enveric Biosciences bags key US patent for mental health drug
Biotech | April 06, 2026

Enveric Biosciences bags key US patent for mental health drug

EB-003 is Enveric’s lead neuroplastogen, a 5-HT2A / 5-HT1B dual-acting compound designed to promote neuroplastic changes


AIIMS New Delhi partners with MediSim VR to advance VR skill training in medical education
Hospitals | April 06, 2026

AIIMS New Delhi partners with MediSim VR to advance VR skill training in medical education

Collaboration to study integration of AI-enabled VR solutions into medical and nursing curricula


CSIR-CFTRI strengthens food innovation ecosystem with BioNEST launch, 26 startups supported
Startup | April 05, 2026

CSIR-CFTRI strengthens food innovation ecosystem with BioNEST launch, 26 startups supported

Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation


Danone India sets record with 20,911 healthcare pledges to fight anemia
Healthcare | April 05, 2026

Danone India sets record with 20,911 healthcare pledges to fight anemia

The record-setting effort stems from Danone India’s nationwide ‘IRON UP!’ campaign


Innovent Biologics’ OLN324 shows breakthrough results in vision disease study
Biopharma | April 05, 2026

Innovent Biologics’ OLN324 shows breakthrough results in vision disease study

The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred


Concord Biotech acquires Celliimune to accelerate DNA-engineered cancer therapies
Biotech | April 04, 2026

Concord Biotech acquires Celliimune to accelerate DNA-engineered cancer therapies

Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy


Kauvery Hospital sets new benchmark in high-risk cardiac care
Hospitals | April 04, 2026

Kauvery Hospital sets new benchmark in high-risk cardiac care

71-year-old high-risk patient with atrial fibrillation and ventricular tachycardia discharged next day